Ondine Biomedical Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	56	36	20	40	108	-
Market Cap Growth	36.09%	79.20%	-50.26%	-63.06%	-	-
Enterprise Value	53	35	18	27	127	-
Last Close Price	0.11	0.09	0.09	0.20	0.56	-
PS Ratio	47.37	31.26	27.74	101.96	72.03	-
PB Ratio	143.75	9.31	16.01	5.59	6.24	-
P/TBV Ratio	143.75	9.31	16.01	5.59	6.24	-
EV/Sales Ratio	45.10	30.82	24.90	69.74	84.97	-
Debt / Equity Ratio	0.76	0.02	0.26	0.12	0.02	-1.04
Net Debt / Equity Ratio	-6.90	-1.40	-1.17	-1.01	-1.00	-1.02
Net Debt / EBITDA Ratio	0.21	0.50	0.17	0.63	1.72	-2.31
Net Debt / FCF Ratio	0.27	0.62	0.18	0.71	2.35	-5.41
Asset Turnover	0.35	0.22	0.11	0.03	0.14	-
Inventory Turnover	0.58	0.62	0.42	0.30	1.80	-
Quick Ratio	0.76	1.73	0.95	3.41	7.81	0.03
Current Ratio	0.97	2.05	1.36	3.87	8.54	0.05
Return on Equity (ROE)	-6414.76%	-426.20%	-209.95%	-93.81%	-	-
Return on Assets (ROA)	-235.98%	-130.98%	-82.98%	-46.25%	-59.55%	-
Return on Capital Employed (ROCE)	-2475.30%	-282.70%	-659.80%	-148.20%	-58.00%	47.90%
Earnings Yield	-22.90%	-29.82%	-43.18%	-29.78%	-27.07%	-
FCF Yield	-17.83%	-24.20%	-41.44%	-25.60%	-6.82%	-
Buyback Yield / Dilution	-68.94%	-39.31%	-1.30%	-144.34%	-12.69%	-761.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.